MORN.NASDAQMorningstar, INC

Form 4: Morningstar Executive Chairman Joseph Mansueto Sells Shares Under 10b5-1 Trading Plan

Sentiment:

SEC Form 4 Filing


Joseph Mansueto, Executive Chairman of Morningstar, Inc., executed multiple sales of common stock between May 17 and May 20, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

  • Joseph D. Mansueto, Executive Chairman of Morningstar, Inc., sold shares of common stock between May 17 and May 20, 2024.
  • The sales were executed under a Rule 10b5-1 trading plan adopted on November 17, 2023.
  • On May 17, 2024, Mansueto sold 3,587 shares at a weighted average price of $299.372 and 698 shares at a weighted average price of $300.1607.
  • On May 20, 2024, he sold 2,538 shares at a weighted average price of $299.1702, 1,613 shares at a weighted average price of $300.4511, and 1,083 shares at a weighted average price of $301.2742.
  • Following these transactions, Mansueto directly owns 10,687,931 shares of common stock.
  • He also indirectly owns 4,752,663 shares through trusts for his benefit and his children, and 150,000 shares through trusts for the benefit of his children.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The document simply reports stock sales under a pre-arranged plan, which is a common practice. There's no indication of positive or negative implications for the company's performance.

Industry Context

Insider selling can sometimes be interpreted negatively by the market, but the existence of a pre-arranged 10b5-1 trading plan often mitigates this concern as it indicates the sales were planned in advance and not based on current inside information.

Comparison to Industry Standards

  • It's common for executives at publicly traded companies, including those like S&P Global, Moody's, and FactSet, to utilize 10b5-1 trading plans for selling shares.
  • The volume of shares sold is relatively small compared to Mansueto's total holdings, which is a common practice to avoid significantly impacting the stock price.
  • The weighted average sale prices are within a normal trading range for Morningstar's stock, indicating the sales were executed at market prices.

Stakeholder Impact

  • The stock sales could have a minor impact on shareholders if the market interprets them negatively, although the 10b5-1 plan should mitigate concerns.
  • There is no direct impact on employees, customers, suppliers, or creditors.

Key Dates

DateDescription
2023-11-17Date of adoption of Rule 10b5-1 trading plan
2024-05-17Date of first stock sale
2024-05-20Date of last stock sale
2024-05-21Date of Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.